Dangerous Deception: Hiding the Evidence of Adverse Drug Effects_NEJM
FDA's slip-shod approval of defective, harmful drugs, accompanied by rubber stampped endorsements by compromised FDA advisory committees may be reaching a boiling point.
-
-
NIMH Chief Child/Adoles Research Blows Wind out TeenScreen Sails_ Los Angeles Times
"Some politicians, public health officials, mental health activists and pharmaceutical companies have worked to establish mental-health screening programs in schools and the community….Researchers and clinicians, meanwhile, say they are far from having developed accurate predictors of a child developing depression. The younger the child, the murkier the crystal ball."
-
Article
From: “VERACARE” To: “Dr. Bart Campbell” Subject: RE: AHRP Response to criticism re: fatal ARDS lung experiment Date: Tue, 1 Jul 2003 ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) https://ahrp.org//testimonypresentations/ARDSNet0603/sharav.html
-
Antidepressant drugs Used as Placebos
Antidepressant drugs Used as Placebos! Fri, 10 Oct 2003 Increased use of antidepressant drugs during the 1990s, has increased national spending on antidepressant drugs by a walloping 600%! Dr. Jay Pomerantz of Harvard writes, “inappropriate use of antidepressant drugs may lead to a deterioration of clinical course with no clear…
-
Informed Consent | Informed Consent Waivers | Investigations | Medical Research Ethics | Unethical Experiments
OHRP Letter to ARDSNetwork re: Investigation of Acute Respiratory DistressSyndrome
OHRP Investigation of experimental treatment for Acute Respiratory Distress Syndrome. ARDSNet studies: ARMA, FACCT, and ALVEOLI Table of Contents to Fax from OHRP page 1 Oct. 7, 2002 OHRP letter to: Ronald S. Newvbower, Ph.D(Mass. General Hospital), Lee E. Limbird, Ph.D. (Vanderbilt University), and Robert Kay, MD) (Cleveland Clinic Foundation)…
-
Psychopharmacology in Turmoil: David Healy, MD Presentation Columbia + Debate Dr. Joseph Coyne, Ph.D
Psychopharmacology in Turmoil: David Healy, MD Presentation Columbia + Debate Dr. Joseph Coyne, Ph.D Fri, 9 Dec 2005 Recent reports describing a determined effort to pathologize US infants and toddlers who are being declared to suffer from “severe mental disorders”–the latest, most aggressively marketed diagnosis for children is Bipolar disorder,…
-
Advisory Committee tells FDA: strengthen warnings on SSRI drug labels now
Advisory Committee tells FDA: strengthen warnings on SSRI drug labels now Wed, 4 Feb 2004 On February 2, more than 60 families and children from all across America testified at a public FDA advisory committee hearing describing (in 2 minutes) how their children suffered drug-induced harm after being prescribed an…
-
What to do about the ADHD epidemic – William B. Carey, M.D.
What to do about the ADHD epidemic William B. Carey, M.D. American Academy of Pediatrics Section on Developmental and Behavioral Pediatrics Newsletter, Autumn 2003, Pages 6-7 In the last two decades the United States has experienced a great increase in the diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) and…
-
AHRP Comments Re: EPA Proposed Rule for Human Pesticide Research
AHRP Comments Re: EPA Proposed Rule for Human Pesticide Research Wed, 30 Nov 2005 Help us stop a proposed government policy that would lead to the proliferation of unthinkable human pesticide experiments such as the infamous CHEERS experiment. CHEERS was designed to expose toddlers to pesticides so that EPA investigators…
-
For the Sake of Public Safety FDA & NIH Must Be Detatched from Drug Industry
For the Sake of Public Safety FDA & NIH Must Be Detatched from Drug Industry Tue, 21 Dec 2004 Daily front page reports about lethal drug effects leave no doubt that we are in the midst of a major health safety and credibility crisis, largely due to a drug development…
-
Doctor Chides Medical Societies to Take Action – GSK Fined $150 Million in Medicare Fraud
Doctor Chides Medical Societies to Take Action – GSK Fined $150 Million in Medicare Fraud Wed, 21 Sep 2005 The latest in a series of fraud settlements, GlaxoSmithKline has agreed to pay $150 million to settle fraud allegations over inflating price of Zorfran and Kytril (nausea drugs) when billing Medicare…
-
NYSOMH Issues Alerts, Guidelines re Antidepressant Use in Children, Teens
NYSOMH Issues Alerts, Guidelines re Antidepressant Use in Children, Teens Wed, 29 Dec 2004 The NYS Office of Mental Health has issued letters and an advisory to state mental health providers “explaining” FDA’s warning and the use of antidepressants in children. As you will note, OMH downplays the meaning of…